Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Investigation

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI5897PMID 10359569PMCID PMC408369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit.

  1998cited by this paper
• Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

  1998cited by this paper
• Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

  1998cited by this paper
• PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

  1998cited by this paper
• Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ

  1998cited by this paper
• IPF2alpha-I: an index of lipid peroxidation in humans.

  1998cited by this paper
• IPF2α-I: An index of lipid peroxidation in humans

  1998cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper
• Deaths: final data for 1996.

  1998cited by this paper
• The Rabbit 15-Lipoxygenase Preferentially Oxygenates LDL Cholesterol Esters, and This Reaction Does Not Require Vitamin E*

  1998cited by this paper
• Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties

  1997cited by this paper
• Cytokine modulation of LDL oxidation by activated human monocytes.

  1997cited by this paper
• Is there a role for 15-lipoxygenase in atherogenesis?

  1997cited by this paper
• The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins).

  1997cited by this paper
• Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.

  1997cited by this paper
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*

  1997cited by this paper
• Nomenclature of isoprostanes: a proposal.

  1997cited by this paper
• Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo *

  1997cited by this paper
• Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

  1997cited by this paper
• The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions.

  1997cited by this paper
• In vivo action of 15-lipoxygenase in early stages of human atherogenesis.

  1997cited by this paper
• The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

  1996cited by this paper
• The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice.

  1996cited by this paper
• Disruption of 12/15-Lipoxygenase Expression in Peritoneal Macrophages

  1996cited by this paper
• Phenylalanine 353 is a primary determinant for the positional specificity of mammalian 15-lipoxygenases.

  1996cited by this paper
• The role of oxidized lipoproteins in atherogenesis.

  1996cited by this paper
• Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.

  1996cited by this paper
• Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

  1995cited by this paper
• Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.

  1995cited by this paper
• Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.

  1995cited by this paper
• Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions.

  1995cited by this paper
• Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase (*)

  1995cited by this paper
• Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.

  1995cited by this paper
• Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

  1995cited by this paper
• Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase.

  1995cited by this paper
• Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate.

  1995cited by this paper
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• Involvement of 15-lipoxygenase in early stages of atherogenesis

  1994cited by this paper
• cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases.

  1994cited by this paper
• ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.

  1994cited by this paper
• Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities.

  1994cited by this paper
• The oxidation hypothesis of atherosclerosis.

  1994cited by this paper
• Markers of mouse macrophage development detected by monoclonal antibodies.

  1994cited by this paper
• Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes.

  1994cited by this paper
• Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases.

  1993cited by this paper
• Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Mammalian lipoxygenases: molecular structures and functions.

  1992cited by this paper
• Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

  1991cited by this paper
• A primary determinant for lipoxygenase positional specificity

  1991cited by this paper
• Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

  1990cited by this paper
• Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.

  1990cited by this paper
• Low density lipoprotein undergoes oxidative modification in vivo.

  1989cited by this paper
• Book ReviewAmbulatory Pediatric Care

  1989cited by this paper
• A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

  1989cited by this paper
• Occurrence of the erythroid cell specific arachidonate 15-lipoxygenase in human reticulocytes.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

  1987cited by this paper
• Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor

  1986cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

  1984cited by this paper
• Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation

  1984cited by this paper
• Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

  1981cited by this paper

• The Role of Lipids in Atherosclerosis: Focus on Molecular Biology Mechanisms and Therapeutic Approaches.

  2025cites this paper
• 12/15-lipoxygenase mediates disturbed flow-induced endothelial dysfunction and atherosclerosis

  2025cites this paper
• 12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation

  2025cites this paper
• Functional humanization of 15-lipoxygenase-1 (Alox15) protects mice from dextran sodium sulfate induced intestinal inflammation

  2025cites this paper
• Regulation of nitric oxide generation and consumption

  2025cites this paper
• Structural and Functional Biology of Mammalian ALOX Isoforms with Particular Emphasis on Enzyme Dimerization and Their Allosteric Properties

  2024cites this paper
• The Octadecanoids: Synthesis and Bioactivity of 18-Carbon Oxygenated Fatty Acids in Mammals, Bacteria, and Fungi

  2024cites this paper
• Holding glycolysis in check though Alox15 activity is required for macrophage M2 commitment and function in tissue repair and anti-helminth immunity

  2024cites this paper
• Cytochrome P450 1B1 is Critical in the Development of TNF-α, IL-6, and LPS-Induced Cellular Hypertrophy.

  2024cites this paper
• Upregulation of ALOX12-12-HETE pathway impairs AMPK-dependent modulation of vascular metabolism in ApoE/LDLR-/- mice.

  2024cites this paper
• Different Structures—Similar Effect: Do Substituted 5-(4-Methoxyphenyl)-1H-indoles and 5-(4-Methoxyphenyl)-1H-imidazoles Represent a Common Pharmacophore for Substrate Selective Inhibition of Linoleate Oxygenase Activity of ALOX15?

  2023cites this paper
• Transgenic mice overexpressing human ALOX15 under the control of the aP2 promoter are partly protected in the complete Freund’s adjuvant-induced paw inflammation model

  2023cites this paper
• Mechanism of Oxidized Phospholipid-related Inflammatory Response in Vascular Ageing.

  2023cites this paper
• Genetic deletion of 12/15 lipoxygenase delays vascular remodeling and limits cardiorenal dysfunction after pressure overload

  2023cites this paper
• Functional Characterization of Transgenic Mice Overexpressing Human 15-Lipoxygenase-1 (ALOX15) under the Control of the aP2 Promoter

  2023cites this paper
• Ferroptosis: A potential target of macrophages in plaque vulnerability

  2023cites this paper
• Bioactive lipid regulation of platelet function, hemostasis, and thrombosis.

  2023cites this paper
• Natural products: potential therapeutic agents for atherosclerosis.

  2022cites this paper
• Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis

  2022cites this paper
• Regulated Necrosis in Atherosclerosis.

  2022cites this paper
• N-Substituted 5-(1H-Indol-2-yl)-2-methoxyanilines Are Allosteric Inhibitors of the Linoleate Oxygenase Activity of Selected Mammalian ALOX15 Orthologs: Mechanism of Action.

  2022cites this paper
• Unraveling the Structure-Dependent Inhibitory Effects of Ginsenoside Series Compounds on Human Cytochrome P450 1B1.

  2022cites this paper
• The Reaction Specificity of Mammalian ALOX15 Orthologs is Changed During Late Primate Evolution and These Alterations Might Offer Evolutionary Advantages for Hominidae

  2022cites this paper
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

  2022cites this paper
• Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

  2022cites this paper
• Arachidonic acid metabolism and inflammatory biomarkers associated with exposure to polycyclic aromatic hydrocarbons.

  2022cites this paper
• New appreciation for an old pathway: the Lands Cycle moves into new arenas in health and disease

  2022cites this paper
• Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease

  2021cites this paper
• Traditional Chinese Medication Tongxinluo Attenuates Lipidosis in Ox-LDL-Stimulated Macrophages by Enhancing Beclin-1-Induced Autophagy

  2021cites this paper
• Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases

  2021cites this paper
• Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis

  2021cites this paper
• Characterization of the Structural Diversity and Structure-Specific Behavior of Oxidized Phospholipids by LC-MS/MS.

  2021cites this paper
• Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

  2021cites this paper
• Novel role of xanthine oxidase-dependent H2O2 production in 12/15-lipoxygenase-mediated de novo lipogenesis, triglyceride biosynthesis and weight gain

  2021cites this paper
• Functional Characterization of Knock-In Mice Expressing a 12/15-Lipoxygenating Alox5 Mutant Instead of the 5-Lipoxygenating Wild-Type Enzyme

  2020cites this paper
• Arachidonate 12S-lipoxygenase of platelet-type in hepatic stellate cells of methionine and choline-deficient diet-fed mice.

  2020cites this paper
• PERİODONTAL HASTALIK, ATEROSKLEROZ VE OKSİDATİF STRES İLİŞKİSİ: DERLEME

  2020cites this paper
• Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation

  2020cites this paper
• The emerging role of COX-2, 15-LOX, and PPARγ in metabolic diseases and cancer: An introduction to novel multi-target directed ligands (MTDLs).

  2020cites this paper
• Role of reactive oxygen species in atherosclerosis: Lessons from murine genetic models.

  2020cites this paper
• A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.

  2020cites this paper
• Role of Poultry Research in Increasing Consumption of PUFA in Humans

  2019cites this paper
• Design, synthesis, molecular docking study and biological evaluation of heteroaryl 2-phenoxypyridin-3-yl derivatives as lipoxygenase enzyme inhibitors

  2019cites this paper
• Regulation and Functions of 15-Lipoxygenases in Human Macrophages

  2019cites this paper
• Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?

  2019cites this paper
• Computer Simulation of the atherosclerotic plaque

  2019cites this paper
• Effects of Early Intervention With Maternal Fecal Bacteria and Antibiotics on Liver Metabolome and Transcription in Neonatal Pigs

  2019cites this paper
• Exercise Promotes Resolution of Acute Inflammation by Catecholamine-Mediated Stimulation of Resolvin D1 Biosynthesis

  2019cites this paper
• Involvement of the Hydroperoxy Group in the Irreversible Inhibition of Leukocyte-Type 12-Lipoxygenase by Monoterpene Glycosides Contained in the Qing Shan Lu Shui Tea

  2019cites this paper
• The effects of oxidative stress on the development of atherosclerosis

  2019cites this paper
• Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death

  2019cites this paper
• Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

  2019cites this paper
• Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

  2019cites this paper
• Mechanistic and Therapeutic Insights of Macrophage MicroRNA in Atherosclerosis

  2019cites this paper
• Heterogeneity of Macrophages in Atherosclerosis

  2019cites this paper
• An integrated approach to simulating the vulnerable atherosclerotic plaque.

  2019cites this paper
• Role of Oxidative Stress, Mitochondrial Dysfunction, and Autophagy in Cardiovascular Disease: Its Pathogenesis and Amelioration by Different Small Natural Molecules

  2019cites this paper
• Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

  2019cites this paper
• Chapter 2 12 / 15-Lipoxygenase Deficiency Promotes the Development of Adipose Tissue Inflammation and Insulin Resistance

  2018cites this paper
• Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.

  2018cites this paper
• A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma1[S]

  2018cites this paper
• Chapter 3 Role of Oxidized LDL in Atherosclerosis

  2018cites this paper
• Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model

  2018cites this paper
• Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

  2018cites this paper
• Identification of Peracetylated Quercetin as a Selective 12-Lipoxygenase Pathway Inhibitor in Human Platelets

  2018influential citation
• High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis

  2018cites this paper
• Synopsis of arachidonic acid metabolism: A review

  2018cites this paper
• MiR-210 protects cardiomyocytes from OGD/R injury by inhibiting E2F3.

  2018cites this paper
• CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.

  2018cites this paper
• Specialized pro-resolving mediators in cardiovascular diseases.

  2017cites this paper
• Effect of Lipoxygenase Oxidation on Surface Deposition of Unsaturated Fatty Acids.

  2017cites this paper
• Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis

  2017cites this paper
• Lipoxygenase-mediated peroxidation of model plant extractives

  2017cites this paper
• Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes

  2017cites this paper
• Myeloid 12/15-LOX regulates B cell numbers and innate immune antibody levels in vivo

  2017cites this paper
• Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)-hydroxyeicosatetraenoic acid–induced monocyte trafficking

  2017cites this paper
• Lectin-like oxidised low density lipoprotein 1 scavenger receptor regulation of signal transduction in cell function and atherosclerosis

  2017cites this paper
• Chapter 3 – Degenerated HDL and Its Clinical Implications

  2017cites this paper
• Oxidized low-density Concerning the Significance of Paraoxonase-1 and SRB 1 Genes in Atherosclerosis

  2017cites this paper
• Protective Effects of Carotenoids in Cardiovascular Disease and Diabetes

  2017cites this paper
• The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol

  2017cites this paper
• The double-edged role of 12/15-lipoxygenase during inflammation and immunity.

  2017cites this paper
• Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols

  2017cites this paper
• New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis

  2017cites this paper
• Chronic Inflammatory Diseases and Endothelial Dysfunction.

  2016cites this paper
• Structural and functional characterisation of dioxolane A3, a new eicosanoid generated by cycooxygenase-1 in platelets

  2016cites this paper
• CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.

  2016cites this paper
• Untersuchungen zum Polymorphismus der alpha – 1 – Antitrypsin – und ALOX15 – Gene in der indonesischen Bevölkerung und die pathophysiologischen Rollen der Enzyme bei der chronisch – obstruktiven Lungenerkrankung (COPD) und Artheriosklerose

  2016influential citation
• Antiatherogenic Roles of Dietary Flavonoids Chrysin, Quercetin, and Luteolin

  2016cites this paper
• Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways.

  2016cites this paper
• Einfluss von Omega-3-Fettsäuren auf postprandiale Triglyceride und Aktivität von Monozyten

  2016influential citation
• Plasma 12- and 15-Hydroxyeicosanoids are Predictors of Survival in Pulmonary Arterial Hypertension

  2016cites this paper
• 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism

  2016cites this paper
• Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease.

  2016cites this paper
• Human Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A3, a Neutrophil-activating Eicosanoid

  2016cites this paper
• An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

  2016cites this paper
• Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.

  2016cites this paper
• Cytokine-Dependent Expression Regulation of ALOX15

  2016influential citation
• Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase

  2016cites this paper
• The Role of Noninvasive Imaging for Detection High Risk Patients with Subclinical Atherosclerosis

  2016cites this paper